Infertility future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infertility}} | {{Infertility}} | ||
{{CMG}} {{AE}} {{NS}} | |||
* Recent advancements in infertility therapy include ovarian tissue preservation, particularly in women undergoing [[chemotherapy]] or [[radiotherapy]]. | |||
* This involves freezing the woman's ovary and reimplanting after she has undergone therapy for future fertility. | |||
* Uterine transplants have been successful in women with [[mullerian agenesis]] to achieve fertility. | |||
* Poor quality of oocytes are seen in older women, which have a higher rate of chromosomal [[aneuploidy]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:33, 30 September 2020
|
Infertility Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Infertility future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Infertility future or investigational therapies |
|
Risk calculators and risk factors for Infertility future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Sanjana Nethagani, M.B.B.S.[3]
- Recent advancements in infertility therapy include ovarian tissue preservation, particularly in women undergoing chemotherapy or radiotherapy.
- This involves freezing the woman's ovary and reimplanting after she has undergone therapy for future fertility.
- Uterine transplants have been successful in women with mullerian agenesis to achieve fertility.
- Poor quality of oocytes are seen in older women, which have a higher rate of chromosomal aneuploidy